Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("JOHNSON, Amy J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 42

  • Page / 2
Export

Selection :

  • and

Molecular Pathways: Targeting Phosphoinositide 3-Kinase p110-Delta in Chronic Lymphocytic LeukemiaHERMAN, Sarah E. M; JOHNSON, Amy J.Clinical cancer research (Print). 2012, Vol 18, Num 15, pp 4013-4018, issn 1078-0432, 6 p.Article

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765HERMAN, Sarah E. M; GORDON, Amber L; HAMDY, Ahmed et al.Blood. 2011, Vol 117, Num 23, pp 6287-6296, issn 0006-4971, 10 p.Article

17-DMAG targets the nuclear factor-κB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionHERTLEIN, Erin; WAGNER, Amy J; WEST, Derek A et al.Blood. 2010, Vol 116, Num 1, pp 45-53, issn 0006-4971, 9 p.Article

Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human PlasmaQING LIU; FARLEY, Katherine L; PHELPS, Mitch A et al.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 620-627, issn 0163-4356, 8 p.Article

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolMAHONEY, Emilia; LUCAS, David M; BLUM, Kristie A et al.Blood. 2012, Vol 120, Num 6, pp 1262-1273, issn 0006-4971, 12 p.Article

Flavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative DisordersLIN, Thomas S; BLUM, Kristie A; SCHAAF, Larry J et al.Journal of clinical oncology. 2010, Vol 28, Num 3, pp 418-423, issn 0732-183X, 6 p.Article

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemiaBYRD, John C; LIN, Thomas S; BROERING, Sarah et al.Blood. 2007, Vol 109, Num 2, pp 399-404, issn 0006-4971, 6 p.Article

RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humansTROEGER, Anja; JOHNSON, Amy J; WOOD, Jenna et al.Blood. 2012, Vol 119, Num 20, pp 4708-4718, issn 0006-4971, 11 p.Article

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaLAPALOMBELLA, Rosa; QINGXIANG SUN; FARMER, Alicia et al.Blood. 2012, Vol 120, Num 23, pp 4621-4634, issn 0006-4971, 14 p.Article

Lenalidomide treatment promotes CD 154 expression on CLL cells and enhances production of antibodies by normal B cells through a P13-kinase-dependent pathwayLAPALOMBELLA, Rosa; ANDRITSOS, Leslie; SMITH, Lisa L et al.Blood. 2010, Vol 115, Num 13, pp 2619-2629, issn 0006-4971, 11 p.Article

Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic LeukemiaANDRITSOS, Leslie A; JOHNSON, Amy J; WANG, Da-Sheng et al.Journal of clinical oncology. 2008, Vol 26, Num 15, pp 2519-2525, issn 0732-183X, 7 p.Article

Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: Down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicityHUSSAIN, Syed-Rehan A; CHENEY, Carolyn M; JOHNSON, Amy J et al.Clinical cancer research. 2007, Vol 13, Num 7, pp 2144-2150, issn 1078-0432, 7 p.Article

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viabilityLANNUTTI, Brian J; MEADOWS, Sarah A; DRUKER, Brian J et al.Blood. 2011, Vol 117, Num 2, pp 591-594, issn 0006-4971, 4 p.Article

Mitochondrial genome sequence of Unionicola parkeri (Acari: Trombidiformes: Unionicolidae): molecular synapomorphies between closely-related Unionicola gill mitesEDWARDS, Dale D; JACKSON, Lesley E; JOHNSON, Amy J et al.Experimental & applied acarology. 2011, Vol 54, Num 2, pp 105-117, issn 0168-8162, 13 p.Article

Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLCHEN, Shih-Shih; CLAUS, Rainer; PLASS, Christoph et al.Blood. 2011, Vol 117, Num 3, pp 862-871, issn 0006-4971, 10 p.Article

The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaLAPALOMBELLA, Rosa; GOWDA, Aruna; MUTHUSAMY, Natarajan et al.British journal of haematology. 2009, Vol 144, Num 6, pp 848-855, issn 0007-1048, 8 p.Article

Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. CommentaryKAY, Neil E; LAPALOMBELLA, Rosa; ANDRITSOS, Leslie et al.Blood. 2008, Vol 112, Num 13, issn 0006-4971, 4785-4786, 5180-5189 [12 p.]Article

Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research ConsortiumJAMES, Danelle F; WERNER, Lillian; NEUBERG, Donna et al.Journal of clinical oncology. 2014, Vol 32, Num 19, pp 2067-2073, issn 0732-183X, 7 p.Article

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic LeukemiaBYRD, John C; FURMAN, Richard R; JONES, Jeffrey A et al.The New England journal of medicine. 2013, Vol 369, Num 1, pp 32-42, issn 0028-4793, 11 p.Article

Phosphatidylinositol 3-kinase-8 inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsHERMAN, Sarah E. M; GORDON, Amber L; GIESE, Neill A et al.Blood. 2010, Vol 116, Num 12, pp 2078-2088, issn 0006-4971, 11 p.Article

Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemiaPHELPS, Mitch A; LIN, Thomas S; MORAN, Mollie E et al.Blood. 2009, Vol 113, Num 12, pp 2637-2645, issn 0006-4971, 9 p.Article

The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivoLUCAS, David M; EDWARDS, Ryan B; GOETTL, Virginia M et al.Blood. 2009, Vol 113, Num 19, pp 4656-4666, issn 0006-4971, 11 p.Article

Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumHUSSAIN, Syed-Rehan A; LUCAS, David M; CROUSER, Elliott D et al.Blood. 2008, Vol 111, Num 6, pp 3190-3199, issn 0006-4971, 10 p.Article

Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaJOHNSON, Amy J; WAGNER, Amy J; CHENEY, Carolyn M et al.British journal of haematology. 2007, Vol 139, Num 5, pp 837-844, issn 0007-1048, 8 p.Article

HulD10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cellsMONE, Andrew P; PENG HUANG; PELICANO, Helene et al.Blood. 2004, Vol 103, Num 5, pp 1846-1854, issn 0006-4971, 9 p.Article

  • Page / 2